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Abstract. Eight chiral esters of quinuclidin-3-ol and butyric, acetic, pivalic and benzoic acid were synthe-
sized as well as their racemic and chiral, quaternary N-benzyl derivatives. All racemic and chiral quater-
nary compounds were studied as substrates and/or inhibitors of horse serum butyrylcholinesterase 
(BChE). The best substrate for the enzyme was (R)-N-benzyl butyrate. The rates of hydrolysis decreased 
in order (R)-butyrate >> (R)-acetate (7-fold slower) > (R)-pivalate (8-fold slower) > (R)-benzoate (9-fold 
slower reaction), while (S)-N-benzyl esters were much poorer substrates (320 (butyrate) - 4360-fold slow-
er (pivalate) than the appropriate (R)-enantiomer). For all (S)-N-benzyl esters excluding (S)-N-benzyl ace-
tate inhibition constants were determined (Ka = 3.3−60 μmol dm
−3). The hydrolysis of racemic mixtures of 
N-benzyl esters proceeded 1.4 (for acetate) − 5.1 (for benzoate) times slower than that of pure (R)-
enantiomers of the corresponding concentrations due to the inhibition with (S)-enantiomers. Change of the 
acyl moiety of the substrate effected both activity and stereoselectivity of the BChE.(doi: 
10.5562/cca1829) 




Azabicyclo[2.2.2]octan-3-ol, its derivatives and other 
quinuclidine compounds display a broad range of bio-
logical activities and pharmaceutical industries have 
large interest to explore them.1 Among other activities, 
they were shown to be potential antidotes against or-
ganophosphorus poisoning caused by warfare agents.2−4 
Quinuclidin-3-ol is a chiral compound which contains an 
asymmetric carbon atom at the position 3 of the bicyclic 
ring. Since the racemates are regarded with suspicion as 
pharmaceuticals (enantiomers can have different activity 
or even toxic effects), the issue of quinuclidin-3-ol reso-
lution has been addressed by using a number of chemi-
cal5−7 and biocatalytic8,9 methods. One of the enzymes 
tested as a biocatalyst was butyrylcholinesterase from 
horse serum (BChE, EC 3.1.1.8.). This enzyme has not 
been used as much as some other esterases for biotrans-
formations in organic chemistry10 because of its prefer-
ence toward positively charged substrates which resem-
ble its best substrate: butyryl choline.11−13 Structural 
similarity among choline and quinuclidin-3-ol implied 
that quinuclidine esters might be good substrates of the 
enzyme. Thus, it was possible to use BChE for the reso-
lution of racemic nonquaternized quinuclidin-3-yl bu-
tyrate8 and for the hydrolysis of (R)- and (S)-quinuclidin-
3-yl benzoates,14−16 stereoselectivity of hydrolyses being 
in favour of the (R)-enantiomer. 
In this paper the synthesis of quaternary, N-benzyl 
derivatives of racemic, (R)- and (S)-quinuclidin-3-yl 
butyrate, acetate, pivalate and benzoate are reported, 
Figure 1. Quaternization with N-benzyl group was used 
because it can be considered as a protecting group 
which can be successfully removed afterwards.17 
All synthesized quaternary compounds were stud-
ied as substrates and/or inhibitors of horse serum BChE 
to determine the potential of BChE as a biocatalyst in 
kinetic resolution of quinuclidine esters. 
Figure 1. Structures of synthesized quinuclidinium esters. 
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EXPERIMENTAL SECTION 
Melting points were determined in open capillaries 
using a Büchi B-540 melting point apparatus and are 
uncorrected. Specific optical rotation values were de-
termined with an Optical Activity LTD automatic pola-
rimeter AA-10 on 589 nm at ambient temperature (≈24 
°C) in methanol. Elemental analyses were performed 
with a Perkin-Elmer PE 2400 Series II CHNS/O Ana-
lyser. IR spectra were recorded with a Perkin-Elmer 
FTIR 1725 X spectrometer. 1H and 13C 1D and 2D 
NMR spectra were recorded with Varian XL-GEM 300 
spectrometer at room temperature. Chemical shifts are 
given in ppm downfield from TMS as internal standard. 
HPLC analyses (Thermo Separation Products, Spectra-
SYSTEM 2000) were performed on a RP18 (Waters, 
SymmetryShield, 5 μm, 3.9×150 mm) column (40 °C). 
The mobile phase used was water/ methanol/ acetoni-
trile/ acetic acid/ triethylamine (60/25/15/0.33/0.2), flow 
rate 1 ml/min. The reactions were carried out in Hei-
dolph UNIMAX 1100 Shaker. BChE (EC 3.1.1.8), type 
IV-S lyophilized powder from horse serum (Sigma 
Chemical Co.) was used without further purification. 
The hydrolysis of esters catalyzed by BChE was moni-
tored by following the production of N-benzyl-
quinuclidin-3-ol by HPLC analysis as described pre-
viously.15 All experiments for (R)-enantiomers were 
performed with 1.5 × 10−9 mol dm−3 and for (S)-en-
antiomers with 1.5 × 10−8 mol dm−3 concentration of 
BChE. The dissociation constants of enzyme-inhibitor 
complex for (S)-enantiomers were determined from 
Hunter-Downs plot, using benzoyl choline (BzCh) as a 
substrate. 
 
Preparation of substrates 
(R)- and (S)- quinuclidin-3-ol were prepared by a reso-
lution procedure as described previously using L- and 
D-tartaric acid.5 All esters were prepared according to 
the procedure described for quinuclidin-3-yl benzoate.14 
N-quaternary derivatives were prepared by the addition 
of benzyl bromide (2 equivalents) to the solution of 
appropriate chiral quinuclidin-3yl ester in dry ether. 
Synthesis and physical properties of benzoates 
(BzBzl)15 and acetates (AcBzl)18 were described pre-
viously. 
 
Quinuclidin-3-yl butyrate, colourless oil, yield 95 %, 
(R)-enantiomer:  23 D[ ]α –22.0° (c = 3, EtOH), (S)-enan-
tiomer  23 D[ ]α +22.0° (c = 3, EtOH); IR (NaCl) ν /cm
−1: 
2948, 2873, 1731 1457, 1310,1257, 1185, 1081, 979, 
779, 753; 1H NMR (CDCl3)  / ppm: 0.93 (t, 3H, −CH3, 
3J = 7.4 Hz), 1.35−1.95 (m, 6H, H5, H8 and −CH2CH3), 
1.95−2.01 (m, 1H, H4), 2.27 (t, 2H, −CH2CH2CH3, 
3J = 
7,4 Hz), 2.62−2.90 (m, 5H, H6, H7 and 1H2 cis), 3.21 
(dd, 1H, H2, 
2J = 14.6 and 3J = 8.5 Hz, trans), 4.66−4.81 
(m, 1H, H3);
 13C NMR (CDCl3)  / ppm: 13.41 (−CH3), 
18.27 (C8), 19.20 (C5), 24.15 (−CH2CH2CH3), 24.91 
(C4), 36.20 (−CH2CH2CH3), 46.16 (C6), 47.07 (C7), 
55.20 (C2), 70.62 (C3), 173.47 (C=O); ESMS: m/z (m/z 
calcd. for C11H20NO2
+, 198.14) found 198.2. 
 
3-Butyryloxy-1-benzylquinuclidinium bromide  
(BuBzl): recrystallization from methanol/ether gave 
white crystals, yield 94 %; m.p. 169.1−170.0 °C (de-
comp.); (R)-enantiomer (RBuBzl):  23 D[ ]α +19.0° (c = 1, 
EtOH); (S)-enantiomer (SBuBzl):  23 D[ ]α −19.0° (c = 1, 
EtOH); UV (EtOH) max/nm: 257, 262 and 269 (log  / 
dm3 mol−1 cm−1: 2.50; 2.55 and 2.42); IR (KBr) ν /cm−1: 
3022, 2955, 2877, 1726, 1461, 1453, 1378, 1283, 1156, 
1002, 980, 706; 1H NMR (CDCl3)  / ppm: 0.86 (t, 3H, 
−CH3, 
3J = 7,4 Hz), 1.50−1.65 (m, 2H, −CH2CH3), 
1.87−2.49 (m, 5H, H5, H8 and H4), 2,34 (t, 2H, 
−CH2CH2CH3, 
3J = 7,4 Hz), 3.31−4.02 (m, 5H, H6, H7 
and 1H2 cis), 4.20−4.40 (m, 1H, H2 trans), 5.05−5.21 
(m, 3H, −CH2− bzl and H3), 7.25−7.71 (m, 5H, bzl); 
13C 
NMR (CDCl3)  / ppm: 13.38 (−CH3), 17.99 (C8), 18.21 
(−CH2CH2CH3), 21.20 (C5), 24.53 (C4), 35.68 
(−CH2CH2CH3), 53.23 (C6), 53.64 (C7), 59.74 (C2), 
66.31 (−CH2− bzl), 66.69 (C3), 126.59 (C1 bzl), 129.00 
(C3, C5 bzl), 130.34 (C4 bzl), 133.18 (C2, C6 bzl), 172.56 
(C=O); ESMS: m/z (calcd. for C12H22NO2
+ 288.20) 
found 288.3. 
Anal. Calcd. mass fractions of elements, w/%, for 
C18H26BrNO2 (Mr = 368.31) are C 58.70, H 7.12, N 
3.80; found: C 57.21; H 7.03; N 3.89. 
 
Quinuclidin-3-yl pivalate, colourless oil, yield 97 %, 
(R)-enantiomer:  27 D[ ] +18.4° (c=2.0; EtOH); (S)-
enantiomer  27 D[ ] −17.9° (c=2.0, EtOH); IR (NaCl) ν
/cm−1: 2954, 2871, 1725, 1668, 1480, 1457, 1396, 1285, 
1163, 1033, 981, 773; 1H NMR (DMSO-d6)  / ppm: 
1.19 (s, 9H, (CH3)3C), 1.31−1.77 (m, 4H, H5 and H8), 
1.85−1.92 (m, 1H, H4), 2.38−2.76 (m, 5H, H6, H7 and 
H2 cis), 3.09 (dd, 1H, H2, 
2J=14.5 i 3J = 8.2 Hz, trans), 
4.60−4.67 (m, 1H, H3); 
13C NMR (DMSO-d6)  / ppm: 
19.41 (C5), 24.05 (C8), 24.98 (C4), 26.91 ((CH3)3C), 
38.28 (C(CH3)3), 45.94 (C6), 46.97 (C7), 55.30 (C2), 
70.71 (C3), 177.46 (C=O); ESMS: m/z (calcd. for 
C12H22NO2
+ 212.16) found 212.2. 
 
3-Pivaloyloxy-1-benzylquinuclidinium bromide  
(PivBzl): recrystallization from methanol/ether gave 
white crystals, yield 86 %; m.p. 166.4−167.4 °; (R)-
enantiomer (RPivBzl): 28D[ ]α –15.0° (c = 1.0, MeOH); 
(S)-enantiomer (SPivBzl):  28 D[ ]α +15.2° (c = 1.0, MeOH); 
UV (EtOH) max/nm: 257, 262 and 269 (log  /dm3 mol−1 
cm−1: 2.50; 2.55 and 2.42); IR (KBr) ν /cm−1: 3032, 
2955, 2877, 1729, 1465, 1455, 1376, 1284, 1157, 1005, 
990, 704; 1H NMR (DMSO-d6)  / ppm: 1.19 (s, 9H, 
(CH3)3C-), 1.81−2.08 (m, 4H, H5, H8), 2.27−2.28 (m, 
1H, H4), 3.42−3.56 (m, 5H, H6, H7, 1H2 cis), 3.87 (dd, 
1H, H2, 
2J = 12.9 and 3J = 8.7 Hz, trans), 4.61−4.72 (m, 
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2H, −CH2− bzl), 4.99−5.00 (m, 1H, H3), 7.50−7.59 (m, 
5H, bzl); 13C NMR (DMSO-d6) /ppm: 18.08 (C5), 
20.49 (C8), 24.20 (C4), 26.79 ((CH3)3C−), 38.28 
((CH3)3C−), 52.10 (C6), 53.80 (C7), 59.83 (C2), 65.64 
(−CH2− bzl), 67.07 (C3), 127.70 (C1 bzl), 129.00 (C3, C5 
bzl), 130.24 (C4 bzl), 133.21 (C2, C6 bzl), 176.91 (C=O); 
ESMS: m/z (calcd. for C19H28NO2
+
 302.21) found 302.2. 
 
Anal. Calcd. mass fractions of elements, w/% , for 
C19H28BrNO2 (Mr = 382.34) are C 59.69, H 7.38, N 
3.66; found: C 60.38, H 7.12, N 3.59. 
 
RESULTS AND DISCUSSION 
Synthesis of quaternary quinuclidinium esters 
Chiral (R)- and (S)-quinuclidin-3-ols were obtained by 
the resolution of racemic quinuclidin-3-yl acetates with 
L- and D-tartaric acid.5 N-benzyl derivatives of racemic, 
(R)- and (S)-quinuclidin-3-yl acetates, benzoates, 
pivalates and butyrates were synthesized by the esterifi-
cation of quinuclidin-3-ol with appropriate anhydride in 
good yields. Quaternization of racemic and chiral esters 
with benzyl bromide followed. The structure and purity 
of all compounds were determined by HPLC, IR, MS, 
elemental analyses, one- and two-dimensional 1H and 
13C NMR. 
 
Hydrolyses of quaternary esters with BchE 
The overall catalytic process of BChE proceeds in three 
steps: initial formation of an enzyme–substrate com-
plex, an acylation step, and deacylation by hydrolysis,19 
Scheme 1. In the reaction sequence, E, S, ES, and EA 
represent free enzyme, substrate, Michaelis complex 
and acyl-enzyme intermediate, respectively. P1 (alcohol) 
and P2 (acid) are products of the hydrolysis. In the case 
of tested quinuclidinium esters, 1-benzyl-3-
hydroxyquinuclidinium is P1 and P2 are acetic, pivalic 
butyric and benzoic acid respectively. 
All tested chiral esters were substrates of the 
BChE, Figure 2. Analyses of the initial rates revealed 
that the hydrolysis of butyric esters was the fastest 
among all examined enantiomers, and that in general the 
(R)-enantiomers are significantly better substrates for 
BChE then (S)-enantiomers. The rates of hydrolysis for 
(R)-enantiomers decreased in order (R)-butyrate >> (R)-
acetate (7-fold slower) > (R)-pivalate (8-fold slower) > 
(R)-benzoate (9-fold slower reaction). The enzyme was 
even more selective in case of (S)-enantiomers: the rates 
of hydrolysis decreased in order (S)-butyrate > (S)-
acetate (10-fold slower) > (S)-benzoate (32-fold slower) 
> (S)-pivalate (103-fold slower), Figure 2, chart B. On 
the other hand, difference in the initial rates for each 
pair of enantiomers was the biggest for pivalates 
(AR/S=4360), then benzoates (AR/S=1180), acetates 
(AR/S=450) and butyrates (AR/S=320). 
 
Inhibition of BChE by (S)-enantiomers 
Since the rates of hydrolysis of (S)-enantiomers were 
much slower than the rate of hydrolysis of benzoyl 
choline (BzCh) which can be used to monitor enzyme 
Figure 2. The initial rates of BChE catalyzed hydrolysis of A) (R)-esters (A(BChE)/μmol dm−3 min−1 mg−1 equals 2069 for
RBuBzl, 280 for RAcBzl, 263 for RPivBzl and 236 for RBzBzl) and B) (S)-esters (A(BChE)/μmol dm−3 min−1 mg−1 equals
6.480 for SBuBzl, 0.625 for SAcBzl, 0.063 for SPivBzl and 0.203 for SBzBzl). Monitoring was done by the HPLC analysis of the
products. Concentration of all substrates was 4 mmol dm−3. Each data point represents the average value of three measurements. 
Scheme 1. 
248 I. Primožič et al., Stereoselective BChE-Catalyzed Ester Hydrolysis 
Croat. Chem. Acta 84 (2011) 245. 
activity, it was possible to determine enzyme-inhibitor 
dissociation constant Ki. The enzyme-inhibitor dissocia-
tion constant Ki was calculated from equation 
Kapp=Ki+(Ka/Km)·s, where Kapp is the apparent enzyme-
inhibitor dissociation constant at a given substrate con-
centration (s) and Km is the Michaelis constant for the 
substrate. All (S)-esters acted as reversible inhibitors of 
the enzyme, Table 1. Only SAcBzl inhibited the enzyme 
when concentrations of BzCh were lower than 0.22 
mmol dm−3, and activated the enzyme when the concen-
tration of BzCh was higher, Figure 3. Therefore, it was 
not possible to determine the enzyme-inhibitor dissocia-
tion constant for that compound. 
All other (S)-esters proved to be μmol dm−3 inhibi-
tors, (S)-benzoate was the best inhibitor, closely fol-
lowed by (S)-pivalate. (S)-butyrate had the lowest affin-
ity toward BChE, Table 1. The calculated values of Km 
for the substrate used (BzCh) obtained from kinetic 
studies with inhibitors can be compared with ones ob-
tained from data without inhibitors (Km (BzCh) = 
0.17±0.01).14 It can be concluded that SBuBzl competed 
with BzCh only in the active site while SPivBzl and 
especially SBzBzl competed with the substrate in the 
peripheral site as well. 
To further explore the hydrolysis reaction of ra-
cemic N-benzyl quinuclidin-3-ol esters catalysed by 
BChE, kinetic experiments were carried out to deter-
mine the differences in rates of hydrolysis of pure (R)-
enantiomers (2 mmol dm−3 solution) and racemic mix-
tures which contained the same concentration of (R)-
enantiomer (4 mmol dm−3 solution of the racemate). The 
obtained values for enzymic activity are presented in 
Table 2. 
All reactions of racemate mixtures were slower 
than the ones of pure (R)-enantiomers. The hydrolysis 
of RBuBzl was 2.0-fold, RPivBzl 2.7-fold faster, while 
that of RBzBzl was the fastest (5.1-fold) in comparison 
to the appropriate racemate. These data are in accor-
dance with the measured inhibition constants for (S)-
enantiomers, SBzBzl beeing the best inhibitor, followed 
by (S)-pivalate and (S)-butyrate. It is interesting that in 
the case of racemic AcBzl there was no effect of activa-
tion with present SAcBzl because RAcBzl was the sub-
strate instead of BzCh, Figure 3., in the enzyme activity 
measurements. The hydrolysis of RAcBzl was 1.4-fold 
faster when (S)-enantiomer was not present, thus the 
inhibition of SAcBzl was the lowest in magnitude 
Table 1. Inhibition constants of BChE by (S)-N-benzyl esters: 
the enzyme-inhibitor dissociation constant Ki and standard 
deviation was obtained from four experiments on average. The 
dissociation constant of enzyme-inhibitor complex was deter-





SBuBzl 0,19 ± 0,01 60,5 ± 0,5 
SPivBzl 0,79 ± 0,02 12,3 ± 0,2 
SBzBzl15 1,6 ± 0,6 3,3 ± 0,4 
Km corresponds to (k−1/k1 + k2/k1)[k3/(k2 + k3)] 
Figure 3. The kinetic study of inhibitory effectiveness of 
SAcBzl toward BChE in catalyzed hydrolyses of BzCh. Each 
data point represents the average value of three measurements. 
Concentrations of SAcBzl are expressed in mmol dm−3. 
Table 2. Activity of BChE (A) measured for racemic mixtures and (R)-enantiomers of all compounds: 4 mmol dm−3 solution of 
racemate and 2 mmol dm−3 solution of (R)-enantiomer. Each data point represents the average value of three measurements. 
AR/racemate  corresponds to the ratio of BChE activity for (R)-enantiomer and racemate 
Substrate 
A(BChE)/mmol dm−3 min−1 mg−1   
(R)-enantiomer Racemate AR/racemate 
Inhibition by (S)-enantiomer / 
% 
BuBzl 0.993 0.502 2.0 50 
AcBzl 0.184 0.129 1.4 29 
PivBzl 0.252 0.094 2.7 63 
BzBzl 0.406 0.080 5.1 80 
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among (S)-enantiomers. The BChE catalysed hydrolysis 
of RBzBzl was slower in case of 4mmol dm−3 solution 
(Fig. 2.) than in case of 2 mmol dm−3 solution (Table 2.) 
indicating inhibition by substrate (RBzBzl) when the 
higher substrate concentrations are present. 
 
CONCLUSION 
We have prepared racemic and enantiomerically pure 
esters of chiral quaternary N-benzyl quinuclidin-3-ol 
and butyric, acetic, pivalic and benzoic acid. Kinetic 
studies of BChE-catalyzed ester hydrolysis showed that 
the reaction proceeds in a stereoselective manner: (R)-
enantiomers were hydrolyzed preferentially. On the 
other hand, (S)-enantiomers showed much higher affin-
ity toward BChE and all were determined as µmol dm−3 
inhibitors of the enzyme with the exception of the ace-
tate derivative. It was revealed that there is a great 
influence of the acyl moiety both on the activity and 
stereoselectivity of the hydrolysis. The best substrates 
for the enzyme were butyrates which acyl group is the 
same as the one in butyrilcholine. Their acyl group 
fitted the best in the acyl binding site of the enzyme 
compared to other esters, resulting with the fastest 
reactions but, at the same time, with the loss of selec-
tivity towards enantiomers. Smaller acetate group and 
bigger pivalate and benzoate could not realize a maxi-
mum possible interactions and the activity of the en-
zyme was lower. Among (S)-enantiomers, the differ-
ences in the activity of BChE were even more pro-
nounced and partly related to their inhibitory proper-
ties. Effective inhibition of the enzyme indicates that 
there is a strong non-productive binding of (S)-
enantiomers which can realize stabilizing contacts 
within the active site.14,16 
Due to the satisfactory difference in the rates of 
hydrolysis of enantiomers, BChE can be used as a bio-
catalyst in preparations of optically pure quaternary 
quinuclidin-3-ols. N-benzyl group can be efficiently 
removed by catalytic transfer hydrogenation,20 thus 
regenerating chiral quinuclidin-3-ols, precursors for the 
synthesis of a range of pharmacologically interesting 
analogues. Consequently, kinetic resolution of racemic 
N-benzyl quinuclidinium esters can be successfully 
achieved by the stereoselective hydrolysis catalysed 
with BChE. 
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